Laetitia Marliac-Daubisse

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

How Many Attended the Oncogenetic Consultation, When, and Who?: A Population-Based Study Among Relatives of French Patients With Cancer.

How Many Attended the Oncogenetic Consultation, When, and Who?: A Population-Based Study Among Relatives of French Patients With Cancer.

Journal: Cancer nursing

Published: June 14, 2026

Variation in net survival and in the excess mortality hazard for breast cancer according to stage and age at diagnosis.

Variation in net survival and in the excess mortality hazard for breast cancer according to stage and age at diagnosis.

Journal: Cancer epidemiology

Published: March 24, 2026

More than two-thirds of patients with prostate cancer have the same or even a greater survival than the general male population: A French population-based study from Francim network of cancer registries.

More than two-thirds of patients with prostate cancer have the same or even a greater survival than the general male population: A French population-based study from Francim network of cancer registries.

Journal: The French journal of urology

Published: July 11, 2025

Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study.

Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 10, 2025

Trends in the Incidence of Cancer Among Adolescents and Young Adults Between 2000 and 2020: A Study Based on French Population-Based Registry Data.

Trends in the Incidence of Cancer Among Adolescents and Young Adults Between 2000 and 2020: A Study Based on French Population-Based Registry Data.

Journal: Journal of adolescent and young adult oncology

Published: March 17, 2025

Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39 countries and territories.

Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39 countries and territories.

Journal: Lancet (London, England)

Published: March 15, 2025

Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study.

Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 01, 2024

Access to primary care and mortality in excess for patients with cancer in France: Results from 21 French Cancer Registries.

Access to primary care and mortality in excess for patients with cancer in France: Results from 21 French Cancer Registries.

Journal: Cancer

Published: February 19, 2024

The 2022 ENCR Recommendations on recording and reporting of urothelial tumours of the urinary tract.

The 2022 ENCR Recommendations on recording and reporting of urothelial tumours of the urinary tract.

Journal: Frontiers in oncology

Published: September 16, 2022

Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?

Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?

Journal: International journal of environmental research and public health

Published: February 03, 2022

Treatment time interval in breast cancer: A population-based study on the impact of type and number of cancer centres attended.

Treatment time interval in breast cancer: A population-based study on the impact of type and number of cancer centres attended.

Journal: European journal of cancer care

Published: December 23, 2021

Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).

Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).

Journal: The British journal of dermatology

Published: December 17, 2021

Showing 1-12 of 40

Last Updated: 09/26/2026